§ 13F · FUND PROFILE
SILVERARC CAPITAL MANAGEMENT, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $742M (13F)Positions · 82Turnover · — · Q1Filed · May 14, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$268M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | — | SPDR SERIES TRUST | 825K | $105M | 10.8% | NEW |
| 2 | KALV | KALVISTA PHARMACEUTICALS INC | 2.88M | $58M | 5.9% | +19% |
| 3 | DNTH | DIANTHUS THERAPEUTICS INC | 655K | $55M | 5.6% | −13% |
| 4 | COGT | COGENT BIOSCIENCES INC | 1.31M | $51M | 5.2% | +6% |
| 5 | CELC | CELCUITY INC | 358K | $41M | 4.2% | −5% |
| 6 | IMNM | IMMUNOME INC | 1.85M | $40M | 4.1% | +64% |
| 7 | KOD | KODIAK SCIENCES INC | 992K | $38M | 3.9% | −3% |
| 8 | NUVL | NUVALENT INC | 355K | $36M | 3.7% | +14% |
| 9 | ABVX | ABIVAX SA | 303K | $34M | 3.4% | −28% |
| 10 | GLUE | MONTE ROSA THERAPEUTICS INC | 2.00M | $33M | 3.4% | +95% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE SILVERARC SIGNAL
AC read
SILVERARC CAPITAL MANAGEMENT, LLC is a Other fund managing $742 million in assets. The fund runs a portfolio of 82 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
2 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed